Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Clinical Trial of Oral Medication for CTD-ILD Treatment
Brief Summary: The first objective of this protocol is to assess the tolerability and safety of N-acetylcysteine (NAC) in patients with connective tissue disease related interstitial lung disease (CTD-ILD).